These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 32108588

  • 1. Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.
    Liu Q, Cai P, Guo S, Shi J, Sun H.
    Aging (Albany NY); 2020 Feb 28; 12(4):3713-3729. PubMed ID: 32108588
    [Abstract] [Full Text] [Related]

  • 2. EM-E-11-4 increases paclitaxel uptake by inhibiting P-glycoprotein-mediated transport in Caco-2 cells.
    Liu Q, Sun H, Chen XG, Li Y, Chen H, You F, Bao XQ, Zhang D, Shi JG.
    J Asian Nat Prod Res; 2015 Feb 28; 17(6):649-55. PubMed ID: 26045195
    [Abstract] [Full Text] [Related]

  • 3. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P, Lu P, Sharom FJ, Fang WS.
    Cancer Lett; 2013 Dec 01; 341(2):214-23. PubMed ID: 23941826
    [Abstract] [Full Text] [Related]

  • 4. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH, Wang C, Ojima I, Horwitz SB.
    J Nat Prod; 2018 Mar 23; 81(3):600-606. PubMed ID: 29517223
    [Abstract] [Full Text] [Related]

  • 5. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z, Liu X, Guan Q, Ding N, Wei Q, Tong B, Zhao M, Zhang W, Ma L.
    Chem Biol Interact; 2020 Jan 05; 315():108886. PubMed ID: 31682804
    [Abstract] [Full Text] [Related]

  • 6. Lathyrane diterpenes from Euphorbia lathyris and the potential mechanism to reverse the multi-drug resistance in HepG2/ADR cells.
    Yang T, Wang S, Li H, Zhao Q, Yan S, Dong M, Liu D, Chen X, Li R.
    Biomed Pharmacother; 2020 Jan 05; 121():109663. PubMed ID: 31751870
    [Abstract] [Full Text] [Related]

  • 7. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 9. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM.
    Invest New Drugs; 2020 Jun 21; 38(3):584-598. PubMed ID: 31177401
    [Abstract] [Full Text] [Related]

  • 10. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Jun 21; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 11. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y.
    Toxicol In Vitro; 2020 Dec 21; 69():104971. PubMed ID: 32805372
    [Abstract] [Full Text] [Related]

  • 12. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y, Dai CL, Shi Z, Chen X, Fu L, Ambudkar SV, El Sayed K, Chen ZS.
    Biochem Pharmacol; 2010 Nov 15; 80(10):1497-506. PubMed ID: 20696137
    [Abstract] [Full Text] [Related]

  • 13. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
    Wu ZL, Chen Y, Qu Z, Wu GY, He XF, Huang JW, Meng QQ, Hu YH, Shen XL, Yang RY, Hu YJ.
    J Ethnopharmacol; 2022 Aug 10; 294():115353. PubMed ID: 35533911
    [Abstract] [Full Text] [Related]

  • 14. TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.
    Jia L, Gao X, Fang Y, Zhang H, Wang L, Tang X, Yang J, Wu C.
    Apoptosis; 2022 Dec 10; 27(11-12):1015-1030. PubMed ID: 36107354
    [Abstract] [Full Text] [Related]

  • 15. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J, Xia M, Liu W, Li L, Yang J, Mei Y, Meng Q, Xie Y.
    Eur J Pharmacol; 2019 Jun 05; 852():231-243. PubMed ID: 30959046
    [Abstract] [Full Text] [Related]

  • 16. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines.
    Zhao Y, Xu S, Hao W, Fu Y.
    Cell Biochem Funct; 2024 Jul 05; 42(5):e4083. PubMed ID: 38938150
    [Abstract] [Full Text] [Related]

  • 17. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, Reznik SE, Chen ZS.
    Cancer Lett; 2019 Feb 01; 442():91-103. PubMed ID: 30391357
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H, Gotanda T, Oku S, Imazono Y, Kubo H, Hanada T, Suzuki S, Inomata K, Kishiye T, Tahara Y, Nishiyama K, Nakagawa M.
    Jpn J Cancer Res; 2002 Sep 01; 93(9):1037-46. PubMed ID: 12359058
    [Abstract] [Full Text] [Related]

  • 19. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
    Dinić J, Podolski-Renić A, Jovanović M, Musso L, Tsakovska I, Pajeva I, Dallavalle S, Pešić M.
    Int J Mol Sci; 2019 Sep 16; 20(18):. PubMed ID: 31527404
    [Abstract] [Full Text] [Related]

  • 20. [Down-regulated βIII-tubulin expression can reverse paclitaxel resistance in A549/taxol cells lines].
    Zhuo Y, Guo Q.
    Zhongguo Fei Ai Za Zhi; 2014 Aug 20; 17(8):581-7. PubMed ID: 25130963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.